Advancing UK drug policy towards an evidence-based approach.
Our mission is to reduce harm, enhance public health and unlock medical and economic benefit — guided by scientific insight and a commitment to human rights.
Our workstreams
All workstreams →Reducing drug-related deaths
Advocating for evidence-based harm reduction — naloxone access, overdose prevention centres and safer consumption — after 12 consecutive years of rising fatalities.
Learn more →The Feilding Commission
An independent body developing a UK framework for the safe, ethical and equitable rollout of psychedelic-assisted therapy.
Learn more →Honoured in the Pacific, banned in the UK
Campaigning with the UK Kava Coalition to reopen the 2002 ban so the South Pacific diaspora can access kava safely and legally.
Learn more →We promote evidence-based drug policy.
The Centre works on a cross-party basis to draw Parliamentarians' attention to the injustices and inadequacies of existing drug policy. We provide expert advice and briefings to government, opposition and other UK and international decision makers.
Our unique insight blends trusted, balanced evidence with political nous.
About the Centre →The Centre for Evidence Based Drug Policy team is highly effective — their outcomes-driven approach gets things done. They have brought about change in the fields of psychedelics policy, reducing barriers to research, and setting reasonable phytocannabinoid limits for CBD.

